0078-0673 : Hycamtin 1 mg Oral Capsule
NDC: | 0078-0673 |
Labeler: | Novartis Pharmaceuticals Corporation |
Product Type: | Human Prescription Drug |
Drug Name: | Hycamtin |
Dosage Form: | Oral Capsule |
Application #: | NDA020981 |
Rev. Date: |
Appearance:
Markings: | HYCAMTIN;1mg |
Shapes: |
Capsule |
Colors: |
Pink |
Size (mm): | 18 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 0078-0673-01: 10 CAPSULE IN 1 BOTTLE (0078‑0673‑01)
Active Ingredients:
- Topotecan Hydrochloride
Dosage Strength:
- 1 mg
Inactive Ingredients:
- Glyceryl Monostearate
- Gelatin
- Titanium Dioxide
- Ferric Oxide Red
Pharmaceutical Classes:
- Topoisomerase Inhibitor [EPC]
- Topoisomerase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 0078-0672 Hycamtin .25 mg Oral Capsule by Novartis Pharmaceuticals Corporation
- 0078-0674 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Novartis Pharmaceuticals Corporation
- 0007-4201 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline LLC
- 0007-4205 Hycamtin 0.25 mg Oral Capsule by Glaxosmithkline LLC
- 0007-4207 Hycamtin 1 mg Oral Capsule by Glaxosmithkline LLC
- 12064-000 Hycamtin .25 mg Oral Capsule by Glaxosmithkline Manufacturing Spa
- 12064-001 Hycamtin 1 mg Oral Capsule by Glaxosmithkline Manufacturing Spa
- 12064-002 Hycamtin 4 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0078-0672Next: 0078-0674 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.